| Diana L Hartwig, LISW-S | |
|
23715 Mercantile Rd Ste A203, Beachwood, OH 44122-5918 | |
| (216) 292-2880 | |
| Not Available |
| Full Name | Diana L Hartwig |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 10 Years |
| Location | 23715 Mercantile Rd Ste A203, Beachwood, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053874859 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Psycho Social Therapies,ltd | 9234165424 | 12 |
News Archive
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that it has been awarded a non-taxable grant of approximately $245,000 related to Silenor® (doxepin) under the Qualifying Therapeutic Discovery Project (QTDP) program included in the Patient Protection and Affordable Health Care Act of 2010.
Long travel distances continue to be a significant obstacle to breast reconstruction after mastectomy for breast cancer, reports a study in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
The news about remdesivir, the investigational anti-viral drug that has shown early promise in the fight against COVID-19, keeps getting better.
People with high levels of hostility are like to have poor sleep quality, suggests research showing a robust link between the two features.
› Verified 4 days ago
| Entity Name | Psycho Social Therapies,ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750335261 PECOS PAC ID: 9234165424 Enrollment ID: O20051208000882 |
News Archive
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that it has been awarded a non-taxable grant of approximately $245,000 related to Silenor® (doxepin) under the Qualifying Therapeutic Discovery Project (QTDP) program included in the Patient Protection and Affordable Health Care Act of 2010.
Long travel distances continue to be a significant obstacle to breast reconstruction after mastectomy for breast cancer, reports a study in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
The news about remdesivir, the investigational anti-viral drug that has shown early promise in the fight against COVID-19, keeps getting better.
People with high levels of hostility are like to have poor sleep quality, suggests research showing a robust link between the two features.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Diana L Hartwig, LISW-S 23715 Mercantile Rd Ste A203, Beachwood, OH 44122-5918 Ph: (216) 292-2880 | Diana L Hartwig, LISW-S 23715 Mercantile Rd Ste A203, Beachwood, OH 44122-5918 Ph: (216) 292-2880 |
News Archive
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that it has been awarded a non-taxable grant of approximately $245,000 related to Silenor® (doxepin) under the Qualifying Therapeutic Discovery Project (QTDP) program included in the Patient Protection and Affordable Health Care Act of 2010.
Long travel distances continue to be a significant obstacle to breast reconstruction after mastectomy for breast cancer, reports a study in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
The news about remdesivir, the investigational anti-viral drug that has shown early promise in the fight against COVID-19, keeps getting better.
People with high levels of hostility are like to have poor sleep quality, suggests research showing a robust link between the two features.
› Verified 4 days ago
Mrs. Diana Jo Leigh, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24100 Chagrin Blvd, Suite 370, Beachwood, OH 44122 Phone: 216-292-6520 Fax: 216-831-2351 | |
Ms. H. Ross Lowenstein, MSSA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 29525 Chagrin Blvd., Suite 303, Beachwood, OH 44122 Phone: 216-464-4664 | |
Sheryl Markowitz, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24800 Highpoint Rd, Beachwood, OH 44122 Phone: 216-831-6611 | |
Darlene Mason, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 23715 Mercantile Rd Ste A203, Beachwood, OH 44122 Phone: 216-292-2880 | |
Joan Arnson, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 23604 Ranch Rd, Beachwood, OH 44122 Phone: 216-360-0662 | |
Mrs. Sarah Elizabeth Dietrich, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 23240 Chagrin Blvd Ste 270, Beachwood, OH 44122 Phone: 216-765-0500 | |
Ashley Michelle Gulley, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 25201 Chagrin Blvd Ste 390, Beachwood, OH 44122 Phone: 216-209-7830 |